• 2007

Company Description

Andrew Technologies is a medical technology company.

Andrew Technologies, LLC, is a medical technology company with a proprietary surgical innovation called Tissue Liquefaction Technology:tm:. The first product to utilize TLT was launched in 2003 by Alcon for cataract surgery. In 2012, the FDA cleared HydraSolve:registered: Lipoplasty System. Andrew Technologies also has an impressive research pipeline focused on stem cells and diabetes.